What evidence supports the use of the CardioFlex Elite DES for percutaneous coronary intervention with drug-eluting stent placement in de novo native coronary artery lesions in patients with atherosclerotic heart disease or non-ST-elevation myocardia
No direct evidence for CardioFlex Elite DES in PCI for de novo native coronary lesions in atherosclerotic heart disease or NSTEMI patients was identified, highlighting a need for dedicated clinical studies.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-17
- DOI
- https://doi.org/10.5281/zenodo.24297057
- Primary Topic
- Coronary Interventions and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00